The latest clinical win follows a dual set of phase 3 and phase 2 results back in March. In that data drop, Mineralys reported that lorundrostat reduced systolic blood pressure in a late-stage study ...

Browns Mills, N.J.-based Deborah Heart and Lung Center named Geurys Rojas-Marte, MD, medical director of advanced heart failure and pulmonary hypertension programs, the hospital said in a June 14 ...

Shares of Mineralys Therapeutics Inc. (NASDAQ:MLYS) jumped 7.9% following the release of promising topline data from the ...